Latest news
TENX Stock Whipsaws As Traders Eye Volatility And Cash Pile - StocksToTradeStocksToTrade · Mon, 10 Aug 2026 13:17:00 GMTTenax shares nosedive as heart failure drug fails in Phase 3 - BioSpaceBioSpace · Mon, 10 Aug 2026 13:00:18 GMTTenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF - investingnews.cominvestingnews.com · Mon, 10 Aug 2026 12:54:11 GMTTenax Therapeutics (NASDAQ:TENX) Drops 85% as Phase 3 LEVEL Study Fails to Meet Main Endpoints - TechStock²TechStock² · Mon, 10 Aug 2026 12:46:29 GMTTenax Therapeutics (TENX) Reports Phase 3 LEVEL Trial Results, F - GuruFocusGuruFocus · Mon, 10 Aug 2026 12:19:57 GMTTenax Therapeutics Stock Plummets 84% After Phase 3 Trial Failure - StockInvest.usStockInvest.us · Mon, 10 Aug 2026 12:13:05 GMTHeart failure drug from Tenax Therapeutics fails in pivotal study - STATSTAT · Mon, 10 Aug 2026 11:43:53 GMTTenax Therapeutics reports Phase 3 LEVEL topline: missed primary but strong biomarker and subgroup signals - TradingViewTradingView · Mon, 10 Aug 2026 11:23:01 GMT